» Articles » PMID: 37566044

PP2A-Mediated GSK3β Dephosphorylation Is Required for Protocadherin-7-Dependent Regulation of Small GTPase RhoA in Osteoclasts

Overview
Journal Cells
Publisher MDPI
Date 2023 Aug 11
PMID 37566044
Authors
Affiliations
Soon will be listed here.
Abstract

Protocadherin-7 (Pcdh7) is a member of the non-clustered protocadherin δ1 subgroup of the cadherin superfamily. Pcdh7 has been revealed to control osteoclast differentiation by regulating Rho-family small GTPases, RhoA and Rac1, through its intracellular SET binding domain. However, the mechanisms by which small GTPases are regulated downstream of Pcdh7 remain unclear. Here, we demonstrate that protein phosphatase 2A (PP2A)-mediated dephosphorylation of Glycogen synthase kinase-3β (GSK3β) is required for Pcdh7-dependent activation of RhoA during osteoclast differentiation. Pcdh7-deficient (Pcdh7) cells showed impaired PP2A activity, despite their normal expression of PP2A. GSK3β, whose activity is regulated by its inhibitory phosphorylation at Ser9, was dephosphorylated during osteoclast differentiation in a Pcdh7-dependent manner. Inhibition of protein phosphatase by okadaic acid reduced dephosphorylation of GSK3β in Pcdh7 cells, while activation of PP2A by DT-061 rescued impaired dephosphorylation of GSK3β in Pcdh7 cells. Inhibition of GSK3β by AR-A014418 inhibited RANKL-induced RhoA activation and osteoclast differentiation in Pcdh7 cells. On the other hand, DT-061 treatment rescued impaired RhoA activation and RANKL-induced osteoclast differentiation in Pcdh7 cells. Taken together, these results demonstrate that PP2A dephosphorylates GSK3β and thereby activates it in a Pcdh7-dependent manner, which is required for activation of small GTPase RhoA and proper osteoclast differentiation.

Citing Articles

Protocadherin-7 Regulates Monocyte Migration Through Regulation of Small GTPase RhoA and Rac1.

Kim H, Takegahara N, Choi Y Int J Mol Sci. 2025; 26(2).

PMID: 39859288 PMC: 11766416. DOI: 10.3390/ijms26020572.


Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases.

Takegahara N, Kim H, Choi Y Exp Mol Med. 2024; 56(2):264-272.

PMID: 38297158 PMC: 10907717. DOI: 10.1038/s12276-024-01157-7.

References
1.
Bennecib M, Gong C, Grundke-Iqbal I, Iqbal K . Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Lett. 2000; 485(1):87-93. DOI: 10.1016/s0014-5793(00)02203-1. View

2.
Leung L, Urbancic V, Baudet M, Dwivedy A, Bayley T, Lee A . Coupling of NF-protocadherin signaling to axon guidance by cue-induced translation. Nat Neurosci. 2013; 16(2):166-73. PMC: 3701881. DOI: 10.1038/nn.3290. View

3.
Kim H, Takegahara N, Choi Y . Protocadherin-7 Regulates Osteoclast Differentiation through Intracellular SET-Binding Domain-Mediated RhoA and Rac1 Activation. Int J Mol Sci. 2021; 22(23). PMC: 8658210. DOI: 10.3390/ijms222313117. View

4.
Cavallaro U, Christofori G . Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer. 2004; 4(2):118-32. DOI: 10.1038/nrc1276. View

5.
Heggem M, Bradley R . The cytoplasmic domain of Xenopus NF-protocadherin interacts with TAF1/set. Dev Cell. 2003; 4(3):419-29. DOI: 10.1016/s1534-5807(03)00036-4. View